nabumetone has been researched along with Osteoarthritis, Hip in 1 studies
Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.
Osteoarthritis, Hip: Noninflammatory degenerative disease of the hip joint which usually appears in late middle or old age. It is characterized by growth or maturational disturbances in the femoral neck and head, as well as acetabular dysplasia. A dominant symptom is pain on weight-bearing or motion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becvár, R | 1 |
| Urbanová, Z | 1 |
| Vlasáková, V | 1 |
| Vítová, J | 1 |
| Rybár, I | 1 |
| Maldyk, H | 1 |
| Filipowicz-Sosnowska, A | 1 |
| Bernacka, K | 1 |
| Mackiewicz, S | 1 |
| Gömör, B | 1 |
| Rojkovich, B | 1 |
| Siro, B | 1 |
| Bereczki, J | 1 |
| Toth, K | 1 |
| Sukenik, S | 1 |
| Green, L | 1 |
| Ehrenfeld, M | 1 |
| Pavelka, K | 1 |
1 trial available for nabumetone and Osteoarthritis, Hip
| Article | Year |
|---|---|
Nabumetone induces less gastrointestinal mucosal changes than diclofenac retard.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Dicl | 1999 |